Can Point of Care Chest Ultrasound Predicts Pulmonary Complications After

Clinical Trial Summary

This study is done to estimate prevalence of the main detectable lung and cardiovascular complications by an ultrasound realized in room of post-interventional supervision at the patients whose duration of general anesthesia is superior at one hour after a surgery to risk

See also
Status	Clinical Trial	Phase
Completed	`NCT00498251` - Prevention of Lung Edema After Thoracic Surgery	N/A
Completed	`NCT02318199` - Emergence Agitation in Adult Patients After Intracranial Surgery	N/A
Completed	`NCT05762666` - Nociception Level Index as Monitorization of Pain at the Intensive Care	N/A
Terminated	`NCT02541851` - Chronic Pain After Surgical Intensive Care Admission: Incidence and Risk Factors: the DOLOCHROREA Study	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT00498251 - Prevention of Lung Edema After Thoracic Surgery

N/A

Completed

NCT02318199 - Emergence Agitation in Adult Patients After Intracranial Surgery

N/A

Completed

NCT05762666 - Nociception Level Index as Monitorization of Pain at the Intensive Care

N/A

Terminated

NCT02541851 - Chronic Pain After Surgical Intensive Care Admission: Incidence and Risk Factors: the DOLOCHROREA Study

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02979652
Study type	Observational [Patient Registry]
Source	Hospital Nord
Contact	Marc Leone, M.D
Email	mleone@ap-hm.fr
Status	Recruiting
Phase	N/A
Start date	April 2016
Completion date	January 2018

Can Point of Care Chest Ultrasound Predicts Pulmonary Complications After Major Surgery? — POCUSR

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms